Published in Can Dis Wkly Rep on April 07, 1990
Canadian physicians' attitudes about and preferences regarding clinical practice guidelines. CMAJ (1997) 3.56
What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ (2001) 3.15
Public health surveillance: historical origins, methods and evaluation. Bull World Health Organ (1994) 2.09
How best to estimate the global burden of pertussis? Lancet Infect Dis (2003) 2.08
Measles in Canada-1989. Can Dis Wkly Rep (1990) 1.78
A comparison of clinical practice guideline appraisal instruments. Int J Technol Assess Health Care (2000) 1.63
Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine (1997) 1.63
Electric current flow through human skin at power frequency voltages. Br J Ind Med (1969) 1.39
A comparison of local reactions to two formulations of DPT vaccine. Can Commun Dis Rep (1994) 1.38
Meningococcal disease in Canada. Surveillance summary to 1987. Can Dis Wkly Rep (1989) 1.35
Developing a national system for dealing with adverse events following immunization. Bull World Health Organ (2000) 1.32
Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country. HIV Med (2006) 1.32
The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication. Pediatr Infect Dis J (2000) 1.27
Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program--Active (IMPACT). Clin Infect Dis (1999) 1.26
Monitoring childhood immunizations: a Canadian approach. Am J Public Health (1994) 1.24
Variability in prescription drug utilization: issues for research. CMAJ (1996) 1.24
Setting priorities: the Canadian experience in communicable disease surveillance. MMWR Morb Mortal Wkly Rep (1992) 1.16
Congenital toxoplasmosis: epidemiologic features and control. CMAJ (1986) 1.14
Risk behaviour, healthcare access and prevalence of infection with Chlamydia trachomatis and Neisseria gonorrhoeae in a population-based sample of adults in Barbados. Sex Transm Infect (2008) 1.11
Immunization survey of non-institutionalized adults--Quebec (as of May 30, 1996). Can Commun Dis Rep (1996) 1.10
Incidence of Guillain-Barré syndrome in Ontario and Quebec, 1983-1989, using hospital service databases. Epidemiology (1994) 1.10
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
Listeriosis traced to the consumption of alfalfa tablets and soft cheese. N Engl J Med (1990) 1.02
Waiting and interaction times for patients in a developing country accident and emergency department. Emerg Med J (2006) 0.99
Adverse events temporally associated with vaccines--1992 report. Can Commun Dis Rep (1995) 0.99
Drug nomenclature: special notice from the CMA. CMAJ (1993) 0.99
A benefit-cost analysis of two-dose measles immunization in Canada. Vaccine (1998) 0.97
Ensuring vaccine safety in immunization programmes--a WHO perspective. Vaccine (2001) 0.96
Immunization policies in Canadian medical schools. CMAJ (1994) 0.96
Use of mobile phones by medical staff at Queen Elizabeth Hospital, Barbados: evidence for both benefit and harm. J Hosp Infect (2008) 0.93
Eradication of indigenous poliomyelitis in Canada: impact of immunization strategies. Can J Public Health (1989) 0.93
Measles surveillance: guidelines for laboratory support. Working Group on Measles Elimination. Can Commun Dis Rep (1998) 0.93
Changes in adenohypophyseal cytology and nucleic acid content in the rat 32 days after bilateral adrenalectomy and the chronic injection of cortisol. Can J Physiol Pharmacol (1967) 0.90
Trends in the uptake of antenatal voluntary counselling and testing for HIV and HIV prevalence among childbearing women in Barbados, 1993-2004: evidence to gauge the effectiveness of HIV prevention measures. West Indian Med J (2007) 0.89
Quantitative ultrasound of the calcaneus in Arabian women: relation to anthropometric and lifestyle factors. Maturitas (2003) 0.88
Measles in Canada--1988. Can Dis Wkly Rep (1990) 0.87
The reporting and management of adverse reactions to bacillus Calmette-Guérin (BCG) vaccination. Can Dis Wkly Rep (1991) 0.87
Reinforcing surveillance for vaccine-associated adverse events: The Advisory Committee on Causality Assessment. Can J Infect Dis (1996) 0.87
Bone density estimates and risk factors for osteoporosis in young women. East Mediterr Health J (2004) 0.87
Hepatitis B Infection in Canada: Epidemiology and implications for control. Can Fam Physician (1992) 0.86
Failures after immunization with Haemophilus influenzae type b vaccines--1991-1995. Can Commun Dis Rep (1996) 0.84
Rubella reimmunization: comparative analysis of the immunoglobulin G response to rubella virus vaccine in previously seronegative and seropositive individuals. J Clin Microbiol (1996) 0.83
Human listeriosis in Canada-1988. Can Dis Wkly Rep (1989) 0.83
Neonatal listeriosis due to cross-infection confirmed by isoenzyme typing and DNA fingerprinting. J Infect Dis (1991) 0.81
Injection practices in Burkina Faso in 2000. Int J Qual Health Care (2004) 0.81
Use of existing data for public health planning: a study of the prevalence of hepatitis B surface antigen and core antibody in Al Ain Medical District, United Arab Emirates. Bull World Health Organ (2000) 0.81
Carbon source assimilation and fermentation tests: study of 77 animal Pasteurella strains by a microtechnique. Comp Immunol Microbiol Infect Dis (1986) 0.81
Epilepsy and antiepileptic drug use in elderly people as risk factors for dementia. J Neurol Sci (2006) 0.80
Measles outbreak--Baffin region, Northwest Territories. Can Dis Wkly Rep (1991) 0.80
Pertussis in children hospitalized at five Canadian pediatric tertiary care centres. Can Commun Dis Rep (1994) 0.80
Surveillance of vaccine-related adverse events in the first year of life: a Manitoba cohort study. J Clin Epidemiol (1996) 0.79
Mycobacterium tuberculosis transmission in a health clinic. Bull Int Union Tuberc Lung Dis (1992) 0.79
[Aerobic bacterial flora of the nasal cavity of rabbits]. Ann Rech Vet (1986) 0.79
Hepatitis B vaccine and central nervous system demyelinating diseases. Viral Hepatitis Prevention Board. Pediatr Infect Dis J (1999) 0.78
Assessment of the RTS,S/AS01 malaria vaccine. Lancet Infect Dis (2013) 0.78
Decline in Haemophilus influenzae type B invasive infections at five Canadian pediatric centres. Can Commun Dis Rep (1993) 0.78
Childhood pertussis immunization status as reported by parents and the completeness of public-health and physician records in Nova Scotia. Can Commun Dis Rep (1996) 0.77
Preventable deaths related to floods. Am J Public Health (1987) 0.77
Immunity to diphtheria in a sample of the Canadian adult population. Can J Infect Dis (1998) 0.75
Well-baby care and oral polio vaccine. CMAJ (1991) 0.75
Eying guidelines. CMAJ (1996) 0.75
Effects of power frequency voltages on amputated human limb. Br J Ind Med (1969) 0.75
Modelling the incidence of measles in Canada: an assessment of the options for vaccination policy. Vaccine (1998) 0.75
World Health Organization and International Travel and Health. Travel Med Infect Dis (2007) 0.75
[Technic of germectomies of the wisdom teeth]. Ann Odontostomatol (Lyon) (1969) 0.75
[Measurement of oral muscular forces exerted on the vestibular and lingual surfaces of the incisors]. Orthod Fr (1976) 0.75
[Difficulties in the diagnosis of sub- and peri-mandibular tumors]. Ann Odontostomatol (Lyon) (1968) 0.75
[Plasma apolipoproteins]. Union Med Can (1976) 0.75
[Indications for germectomies of wisdom teeth]. Ann Odontostomatol (Lyon) (1969) 0.75
Safe injection practices in a primary health care setting in Oman. East Mediterr Health J (2006) 0.75
[Surgical problems peculiar to germectomies]. Chir Dent Fr (1980) 0.75
[Clinical assessment of the anti-inflammatory and analgetic properties of 16 091 R.P. in dentistry]. Rev Stomatol Chir Maxillofac (1970) 0.75
[Zoonoses in the ORL region]. J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1984) 0.75
Isolation and plaque purification of a syncytial forming component of myxoma virus. Comp Immunol Microbiol Infect Dis (1989) 0.75
Evaluation of the promotional materials used during the measles mass immunization campaign in Ontario and British Columbia. Can J Public Health (1999) 0.75
[New technic of surgical treatment of periapical lesions using carbon dioxide laser]. Rev Odontostomatol (Paris) (1990) 0.75
[Maxillary location of Albright's disease]. Rev Stomatol Chir Maxillofac (1971) 0.75
[Computer focases of class III deep-bite malocclusion]. Orthod Fr (1973) 0.75
[Study of orofacial muscle balance with a new technic using extensometry gauges]. Rev Odontostomatol (Paris) (1976) 0.75
The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996. Can Commun Dis Rep (2000) 0.75
A single dose of an effective whole cell pertussis vaccine does not significantly increase protection in children primed with a less effective vaccine. Vaccine (1999) 0.75
[Insulinoma: report of 2 cases and classification of hypoglycemia]. Union Med Can (1973) 0.75
[Pseudo-tumoral glandular cheilitis]. Ann Odontostomatol (Lyon) (1971) 0.75
Brief report from the third Canadian National Immunization Conference. Paediatr Child Health (1999) 0.75
Immunization safety: a global priority. Bull World Health Organ (2000) 0.75
[Unilateral temporomandibular ankylosis of infectious origin in children]. Rev Stomatol Chir Maxillofac (1994) 0.75
[Plasma apolipoproteins in dyslipoproteinemias. III. LCAT deficiency and other hyperlipidemias]. Union Med Can (1978) 0.75
[Presentation and importance of extensiometric gauges in the measurement of the muscular pressure to which the tooth is subjected]. Ann Odontostomatol (Lyon) (1967) 0.75
Adverse events monitoring as a routine component of vaccine clinical trials: evidence from the WHO Vaccine Trial Registry. Bull World Health Organ (2000) 0.75
[Osteotomy of the median tubercule as a consequence of bilateral complete labio-maxillo-palatal cleft]. Rev Stomatol Chir Maxillofac (1994) 0.75
Meningococcal disease in children hospitalized at six Canadian pediatric tertiary care centres. Can Commun Dis Rep (1994) 0.75
[The problem of tooth extraction in persons called "cardiacs"]. Ann Odontostomatol (Lyon) (1966) 0.75
[Not Available]. Paediatr Child Health (1999) 0.75
Hypotonic-hyporesponsive episodes in children hospitalized at 10 Canadian Pediatric Tertiary-Care Centres, 1991-1994. Can Commun Dis Rep (1997) 0.75
[Dentomaxillofacial changes induced in children wearing the Milwaukee orthopedic device in vertebral scoliosis (old and new model)]. Orthod Fr (1975) 0.75
A community response to an outbreak of pertussis in Yukon. Arctic Med Res (1991) 0.75
[Facial asymmetry due to hemi-mandibular hypertrophy]. Rev Stomatol Chir Maxillofac (1989) 0.75
Investigation into a cluster of infant deaths following immunization: evidence for methanol intoxication. Vaccine (2002) 0.75
[Plasma apoproteins in dyslipoproteinemias. I. The hypolipidemias]. Union Med Can (1977) 0.75
[Plasma apolipoproteins in dyslipoproteinemias. III. Classical hyperlipemias]. Union Med Can (1978) 0.75